\- Male or female subjects 2 to ≤ 17 years of age with confirmed or possible CIDP.
You may not be if
\- Absence of CIDP symptoms
-History or family history of inherited neuropathy
-Diagnosed developmental delay or regression
-History of thrombotic episode
-Known or suspected hypersensitivity to Privigen
-Known allergic or other severe reactions to blood products
-Female subject of childbearing potential either not using or not willing to use a medically reliable method of contraception or not sexually abstinent during the study
-Pregnant or breastfeeding mother"
Clareo Health | Two Dose Levels of Privigen in Pediatric CIDP
